Commercialization: Page 8
-
PharmaVoice Team/PharmaVoice
HealthTech
Headspace and Ginger Merged into Headspace Health Trend Watch: Advancing Digital Health and Therapeutics Support Mental Health Crisis Headspace, a global leader in mindfulness and meditation, and Ginger, a leader in on demand mental healthcare, have merged into Headspace Health, which aims to be ...
By PharmaVoice Team • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Q&A
Last Word: PharmaVOICE The Next Frontier
With Industry Dive acquiring PharmaVOICE, Taren Grom, Editor of PharmaVOICE, sat down with Davide Savenije, Editor-in-Chief of Industry Dive, to discuss what’s coming in 2022, and what you, our community, can expect with the relaunch in January. PV: After 20-plus years as a print publica...
By Davide Savenije • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Technology Solutions: A Technology-Based Industry
From clinical research to regulatory processes to manufacturing and beyond, technology is now well-entrenched in every part of the pharmaceutical industry Technology is part and parcel of the life sciences. It both shapes current and future innovations and, in the age of personalized medicine, is...
By PharmaVoice Team • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
KOL Digital Listening: Going Beyond the Search for Digital Opinion Leaders
Over the past three years the amount of scientific discussion online has accelerated. Digital platforms like social media, websites, blogs, news, and video are being used by the medical community to share new data, discuss treatments, and educate about diseases across all therapeutic areas. Medic...
By Scott Thompson • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Reimagining the SpecialtyRx Patient Journey Through the Lens of a Digital Consumer
Since the onset of COVID, the world has seen a radical shift by consumers to digital channels out of both safety and convenience. This shift has occurred not just for everyday goods and services like online grocery delivery and digital banking, but also with big-ticket decisions — such as 30% of ...
By Scott Snyder • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Data and Technology: The Key to Patient-Centric Clinical Research
A convergence of trends is transforming the trial experience and increasing efficiencies. Patient-centricity has become a driving force in clinical research. Patients expect trials to be built around their needs as a factor of participation, while regulators expect to see more diverse patient ...
By Susan Bacheller & Ann Dokus • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
A Strong Patient Support Partnership: Balancing Technology + Talent
Improve Efficiency and Enhance Patient-Centricity Technology is growing at a fast clip in patient service hubs. Completing information online is the norm for tech-savvy patients, with automation providing speed and cost reduction. At the same time, patients require personal support to access, und...
By Karl Raabe • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
The Rise of the Virtual Rep
For more than three decades, detailing has been one of the cornerstones of the pharmaceutical industry’s communications with physicians. Thanks to recent advances in technology, what started out as face-to-face meetings between pharmaceutical sales representatives and physicians has evolved into ...
By Ralph Greene • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Augmenting AI for Music Therapy Could Be Part of Your Next Marketing Gig!
Music has always been a passion of mine. I’ve been playing the drums for years and it has always been there for me during the good times and very therapeutic in managing the stressful times in my life. Looking back to when I first began to immerse myself in learning how to play, I couldn’t have i...
By Joe Tozzini • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Pandemic Tailwind Accelerating Adoption of AI-Powered Data Analytics Solutions
Throughout history there have been seminal moments in time when humankind has been forced to rethink commonly accepted ways of doing things, as well as the beliefs that have held them in place. In many cases these pivots were brought about by milestone events that forced the reexamination of stan...
By Sagar Anisingaraju • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Engaging Patients and Providers in A Digital World Utilizing Virtual Assistants and In-Workflow Services
It’s evident within our healthcare system just how challenging it can be for patients to receive information and status updates regarding their care. Portals, apps, and websites all pose challenges for patients: remembering logins, potentially missing or incomplete data, and the inability to keep...
By Ron Lacy • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Supply Chain: Addressing Supply-Chain Vulnerabilities
After COVID-19, pharma companies are eyeing different ways to ensure their supply chains remain resilient to future disruptions. When the world was hit by the COVID-19 pandemic, supply chains around the world faced almost instant disruption. The pandemic exposed vulnerabilities and highlighted th...
By PharmaVoice Team • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
The Cost of Overlooking Ancillary Supplies in Protocol Development
Recent upheaval in the global supply chain can no longer be seen through a crisis-control lens. It is a new reality forcing leaders, teams, and entire organizations to fundamentally change their approaches. It is arguable that the impacts are felt most acutely in pharma, where delays carry coloss...
By Joanne Santomauro • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Opinion
Executive Perspective: Data For Better Health Outcomes: A Conversation with Clark Wooten and Anthony Passarelli
The COVID-19 pandemic has continued to disrupt the healthcare market across all sectors, and the digital health segment is no exception. But in this case, there has been a positive boost. According to Global Market Insights, the digital health market exceeded $141.8 billion in 2020 and is estimat...
By Clark Wooten • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Optellum and J&J Initiative Partner on Lung Health AI-driven Clinical Decision Platform Trend Watch: AI Continues to Accelerate R&D Efforts Across Diseases States Optellum, a lung-health AI company, has entered a strategic collaboration with the Lung Cancer Initiative at Johnson & Joh...
By PharmaVoice Team • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Artificial Intelligence: AI Here and Now
Companies have increasingly turned to machine learning and AI to improve R&D, manage costs, and address stakeholder expectations. Artificial intelligence and machine learning are no longer futuristic innovations. Today, AI is widely used within the pharmaceutical industry, with the market exp...
By PharmaVoice Team • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence, Buyer-Intent Data, and Account-Based Marketing: How Technology Has Changed the Way We Do B2B Marketing and Sales
The new world of B2B marketing is now shaped by data-driven decision-making by way of artificial intelligence (AI) and buyer-intent data. These two technologies allow for better understanding of what your customers want and can help you discover hidden business opportunities in near “real time." ...
By Jonathan Agoot • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
AI: Rewriting the Clinical Development Handbook
The life-sciences industry is at a critical and unprecedented inflection point in terms of AI. Since the start of the global pandemic the use of AI by biopharma has gone from tactical to transformational. Traditionally employed during the research phase of R&D to identify drug candidates, syn...
By Jonathan Burr • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Patient Engagement: Digital Control: Putting Solutions Into the Hands of Patients
Patient engagement solutions are key to clinician-patient interaction, improving compliance, enabling real-time reporting, and reducing visits to the doctor and hospital. Patients today want and expect to have greater control over their healthcare journey. They are accustomed to accessing informa...
By PharmaVoice Team • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
From Mass Marketing to Precision Marketing: The Revolution Is Now
The time is now — patients have firmly established themselves as savvy and engaged consumers. And they are becoming more empowered every day — with more access to research and information, online connections to other patients like themselves, and demanding more from a healthcare system that was a...
By Heather Campbell • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Real-World Implications of High-Deductible Health Plans
High deductible health plans (HDHPs) were created 20 years ago to foster a more consumer-driven and affordable healthcare landscape. Have they lived up to that vision? While these plans are beneficial for certain populations, new research suggests they may also play a role in broadening the exist...
By Bonnie MK Donato • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Bridging the Patient Support Gap With Integrated Technology Solutions and Strategies
Each year, medication non-adherence causes 125,000 preventable deaths and $300 billion in avoidable healthcare costs. In a world where patients face more medication barriers than ever, patient support programs are critical in providing value-based care that yields a palpable and lasting impact. T...
By Maria Kirsch • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Social Health: Reinventing the Patient Journey
Welcome to the next generation of the patient journey. It’s a journey that’s no longer vaguely linear — patients are now benefiting from practically infinite human connections enabled and accelerated by digital communication. Those connections have transformed the patient journey from a path to a...
By Jack Barrette • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Three Steps to Innovate Patient Solutions
At the heart of all of our work is meeting patient needs, so let’s take a deep dive into all of the routes currently available to deliver patient solutions. The challenge is to balance the conversation between pragmatism and idealism. To call out the elephant in the room, there’s a big appetite f...
By Corina Kellam • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
The Key Elements to a Successful and Sustainable Patient Engagement Strategy
There are three elements to a successful and sustainable patient engagement strategy: personalized, convenient, and data-driven. Pharma spends $20 billion a year in advertisements driving patients to the noninteractive CTA, “talk to a doctor." By incorporating these three elements, we can transfo...
By Chase Feiger • Oct. 1, 2021
Previous
